Elicio Therapeutics (ELTX) Exchange Rate Effect (2020 - 2026)
Elicio Therapeutics (ELTX) reported Exchange Rate Effect of $5000.0 for Q1 2026, down 83.87% on a YoY basis from $31000.0 in Q1 2025, and up 105.21% quarter-over-quarter from -$96000.0 in Q4 2025.
Elicio Therapeutics (ELTX) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Elicio Therapeutics has reported Exchange Rate Effect for 7 years, with the latest figure at $5000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 83.87% year-over-year to $5000.0; the trailing twelve-month figure through Mar 2026 stood at $22000.0 (down 58.49% YoY), and the FY2025 full-year result was $48000.0, up 118.18% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $5000.0, up from -$96000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $87000.0 in Q2 2022, with the low at -$96000.0 in Q4 2025.
- Historically, Exchange Rate Effect has averaged $5769.2 across 5 years, with a median of $27000.0 in 2024.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 2800.0% — and 2024, when it soared 1700.0%.
- Elicio Therapeutics' Exchange Rate Effect stood at $87000.0 in 2022, then sank by 97.7% to $2000.0 in 2023, then jumped by 1250.0% to $27000.0 in 2024, then tumbled by 455.56% to -$96000.0 in 2025, then surged by 105.21% to $5000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $5000.0 (Q1 2026), -$96000.0 (Q4 2025), and $39000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | -96,000.00 |
| Dec 31, 2025 | -96,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | -81,000.00 |
| Jun 30, 2023 | -81,000.00 |